Michelle Min, MD, MSCi
Associate Professor & Director of Rheumatologic Dermatology, UC Irvine School of Medicine
📍 Irvine, California
Speaker
About Dr. Min
Michelle Min, MD, MSCi, is a board-certified dermatologist and Director of Rheumatologic Dermatology at the UC Irvine School of Medicine, where she is an associate professor. She specializes in the skin manifestations of connective tissue disease, including cutaneous lupus, dermatomyositis, scleroderma, psoriasis, and vasculitis.
Dr. Min is a strong advocate for collaboration between dermatology and rheumatology. She lectures nationally on diagnostic and therapeutic pearls at the intersection of the two specialties, including skin-directed treatments such as botulinum toxin for Raynaud phenomenon.
She earned her medical degree at Boston University School of Medicine, completed her dermatology residency at the Icahn School of Medicine at Mount Sinai, and completed a combined dermatology and rheumatology fellowship at Brigham and Women's Hospital/Harvard Medical School.
Ask Her About
Botulinum toxin for Raynaud phenomenon
Skin biopsy technique for rheumatologists
When to treat in-office and when to refer to dermatology
Emerging therapies for cutaneous lupus and dermatomyositis
Session at the 2026 Growth Summit
Dermatologic Procedures for Rheumatic Diseases: Which Ones Rheumatologists Can Do, Refer, and Bill
Saturday, October 17 · 11:35 a.m. – 12:20 p.m. Speaker
Botulinum toxin for Raynaud phenomenon and digital ulcers was not part of most rheumatology fellowships, and neither was skin biopsy. Both are commonly referred to dermatology, where patients often wait weeks to months, delaying diagnosis or treatment. Learn the clinical applications, practical biopsy technique and specimen handling, where fillers fit in systemic sclerosis, and the coding pearls that turn improved access into areimbursable service in your own office.